
Ross Geiger
Investor
Get their honest, personalized take on your startup.
Sign in to pitch Ross →At a glance
- Full Name
- Ross Geiger
- Title
- Co-Founder & President, Ciro (formerly Director of GTM & Revenue Operations, M33 Growth)
- Firm
- Ciro (acquired by Reevo, July 2026); previously M33 Growth
- Firm Type
- Operator/founder; his M33 Growth role was at a growth-equity firm, not an angel fund. There is no public record of Ross Geiger operating as an independent angel investor — the "Angel Investor / Seed Round" label in the stub appears to be an aggregator mis-classification of his M33 Growth email.
- Investment Stage
- Growth equity (M33 Growth typically invests in Series A and later, previously bootstrapped software/healthcare businesses)
- Sector Focus
- B2B software / vertical SaaS, tech-enabled services, healthcare (M33 Growth); GTM / sales-AI (Ciro)
- Geographic Focus
- United States & Canada
- Location
- San Francisco, California (Ciro is SF-based; M33 Growth is Boston-based)
Background
Ross Geiger is a go-to-market operator and startup founder, best known as the co-founder and President of Ciro, a Y Combinator (S22) AI sales-prospecting company. He holds a BA in Economics and East Asian Studies from Brown University, where he later reconnected with the friends who became his co-founders.
He began his career as a Senior Analyst at Altman Solon, a strategy consultancy focused on the technology, media, and telecom sectors, then moved into commercial roles at Catalant Technologies (an enterprise talent/marketplace software company), where he held client-strategy and enterprise account-management roles. He subsequently joined M33 Growth — a Boston-based growth-equity firm managing 700M+ that backs software, healthcare, and tech-enabled-services companies — where he worked in an operating capacity, rising from Associate to Director of GTM & Revenue Operations. In that role he implemented sales-and-marketing technologies across the firm and its portfolio, rather than sourcing traditional angel deals. His [hidden] email dates to this period.
Between M33 Growth and founding Ciro, he served as VP of Sales at YAPI, a Los Angeles–based dental-practice software company, building out its sales function. In 2022 he teamed with Richard Lee (CEO) and David Winer (CTO) — friends from Brown — to found Ciro, which builds an AI "prospecting agent" that finds prospects, researches buying signals, and drafts personalized outreach from within Slack.
In October 2022, Ciro raised a $3.8M seed round led by CRV, with Y Combinator and SV Angel participating (angels reportedly included founders of Flexport, BuildZoom, and Tegus). On July 8, 2026, Ciro was acquired by Reevo, which folded Ciro's prospecting technology into its AI-native "Revenue Operating System."
Investment Thesis & Focus
- Primary identity is operator/founder, not angel. Public sources classify Ross Geiger as a co-founder/operator; no verifiable record shows him running a personal angel portfolio. Treat the "angel investor / seed" tag with caution.
- M33 Growth (where he worked) thesis: growth-equity checks into previously bootstrapped, capital-efficient B2B software, healthcare, and tech-enabled-services businesses in the US and Canada, typically at Series A and beyond — the firm raised a $260M second fund for exactly this profile.
- His operating lens is GTM/revenue. Across YAPI, M33 Growth, and Ciro, his consistent expertise is sales, revenue operations, and go-to-market tooling — the areas where he adds the most value to a company.
- Comfort with sales-heavy, AI-for-GTM products. Ciro itself reflects what he believes in: automating outbound prospecting, research, and first-draft outreach for revenue teams.
Notable Investments
- Ciro — Co-founded 2022 (YC S22); AI GTM/prospecting agent; raised $3.8M seed (CRV/YC/SV Angel, 2022); acquired by Reevo in July 2026.
- M33 Growth portfolio (firm-level, where he was an operator):
- The Oncology Institute of Hope & Innovation — reached a NASDAQ IPO, an M33 Growth exit.
- Rosnet — restaurant-operations analytics software; received M33 Growth growth investment.
- Pediatrica — healthcare-services company; M33 Growth investment (announced July 2026).
- Other M33 holdings include Apogee Interactive (utility customer-engagement software), BeSmartee (digital mortgage platform), and BFC Software (food-distribution warehouse management).
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.